Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-14

Clinical Trial Update: Clinical Assessment of Urinary Antiseptics Methenamine and Methylthioninium in Recurrent Cystitis [Phase 4]

View source ↗

Summary

Phase 4 trial assessing methenamine and methylthioninium for recurrent cystitis (urinary tract infections) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methenamine (Methenamine)
  • Methylthioninium (methylthioninium)

Snippet

Sponsor: Fundação Educacional Serra dos Órgãos | Conditions: Urinary Tract Infections | Phase 4 | Status: COMPLETED